Mangement of Pulmonary Emboli
Adherence to International Guidelines Directed Risk Stratification and Management of Acute Pulmonary Embolism, an Egyptian Experience
1 other identifier
observational
300
0 countries
N/A
Brief Summary
To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented with acute pulmonary embolism
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedStudy Start
First participant enrolled
January 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 17, 2027
January 3, 2025
December 1, 2024
1.9 years
December 17, 2024
January 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality rate
mortality rate of pulmonary embolism
30 day
Study Arms (1)
To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented
Comparing ESC 2019 criteria for risk stratification and mortality with new scores \[BOVA , modified FAST, PEITHO-3 models \& POPE\]. -Comparing management and outcomes of in hospital and 30 days follow up of pulmonary embolism before and after starting PERT in our center
Eligibility Criteria
treatment of patient with pulmonary embolism according to ECS Guidlines
You may qualify if:
- No includion criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Gerardo F, Faria D, Silverio Antonio P, Baltazar Ferreira J, Beringuilho M, Ferreira H, Fialho I, Miranda I, Sa Pereira Y, Nunes-Ferreira A, Roque D, Santos MB, Morais C, Bravo Baptista S, Augusto JB. PrOgnosis in Pulmonary Embolism (PoPE): 30-Day mortality risk score based on five admission parameters. Rev Port Cardiol. 2024 Jan;43(1):1-8. doi: 10.1016/j.repc.2023.04.011. Epub 2023 Jul 7. English, Portuguese.
PMID: 37423312BACKGROUNDLeidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med. 2022 Apr 30;11(9):2533. doi: 10.3390/jcm11092533.
PMID: 35566658BACKGROUNDCohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007 Oct;98(4):756-64. doi: 10.1160/TH07-03-0212.
PMID: 17938798BACKGROUNDISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014 Oct;12(10):1580-90. doi: 10.1111/jth.12698.
PMID: 25302663BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
December 17, 2024
First Posted
January 3, 2025
Study Start
January 20, 2025
Primary Completion (Estimated)
December 17, 2026
Study Completion (Estimated)
December 17, 2027
Last Updated
January 3, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share